Table 4.
Genotype | wt (%) | Misplac (%) | Ipsil (%) | Trunc (%) | Other (%) | N |
---|---|---|---|---|---|---|
etIs2 | 99.8 | 0.2 | 419 | |||
mnm-5(et5); etIs2 | 87.7 | 8.3 | 3.9 | 0.2 | 432 | |
ten-1(ok641); etIs2 | 86.9 | 8.5 | 3.3 | 1.3 | 459 | |
ten-1(tm651); etIs1 | 83.3 | 14.6 | 2.0 | 246 | ||
mig-14;etIs2 | 85.5 | 0.9 | 0.4 | 3.0 | 10.3 | 234 |
mig-14;etIs2 ok641 | 36.4 | 26.6 | 8.9 | 12.1 | 15.9 | 214 |
sax-3; etIs2 | 68.9 | 5.1 | 7.2 | 2.9 | 15.7 | 235 |
sax-3; etIs2 ok641 | LETHAL | - | ||||
slt-1; etIs2 | 97.3 | 1.9 | 0.8 | 262 | ||
slt-1; etIs2 ok641 | 93.9 | 1.1 | 3.0 | 1.9 | 264 | |
unc-5; etIs2 | 76.8 | 16.0 | 7.2 | 250 | ||
unc-5; etIs2 ok641 | 35.6 | 6.2 | 42.9 | 15.3 | 177 | |
unc-6; etIs2 | 23.7 | 0.4 | 37.9 | 37.9 | 253 | |
unc-6; etIs2 ok641 | 42.2 | 6.6 | 42.2 | 8.3 | 0.6 | 469 |
unc-34; etIs2 | 91.8 | 4.9 | 3.3 | 245 | ||
unc-34; etIs2 ok641 | LETHAL | - | ||||
unc-40; etIs2 | 78.3 | 6.5 | 14.8 | 0.4 | 230 | |
unc-40; etIs2 ok641 | 78.6 | 2.5 | 10.7 | 8.2 | 280 | |
unc-51; etIs2 | 83.7 | 5.9 | 10.4 | 270 | ||
unc-51; etIs2 ok641 | 49.2 | 7.4 | 33.5 | 9.7 | 268 | |
unc-52; etIs2 | 94.4 | 3.7 | 1.8 | 215 | ||
unc-52; etIs2 ok641 | 40.8 | 7.1 | 42.9 | 9.2 | 184 | |
unc-73; etIs2 | 50.4 | 19.9 | 29.7 | 236 | ||
unc-73; etIs2 ok641 | LETHAL | - | ||||
unc-129; etIs2 | 91.7 | 2.0 | 6.3 | 204 | ||
unc-129; etIs2 ok641 | 74.1 | 8.6 | 8.2 | 9.1 | 220 |
Notes
wt: normal
Misplac: M2 cell body mispositioned into the metacorpus
Ipsil: ipsilateral outgrowth
Trunc: truncated distal end
Contra: contralateral outgrowth
Post: posterior outgrowth
Other: Contralateral outgrowths in the case of sax-3;etIs2, unc-6; etIs2 ok641 and unc-40; etIs2. Ectopic dorsal branch, posterior branch, misplaced cell into isthmus, growth posterior from metacorpus back into isthmus in the case of mig-14; etIs2 and mig-14;ok641 etIs2.